J Ashley Jefferson
Overview
Explore the profile of J Ashley Jefferson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jefferson J, Chen K, Hingorani S, Malik A, Tykodi S, Keller K, et al.
Glomerular Dis
. 2025 Feb;
5(1):74-83.
PMID: 39991196
Introduction: Minimal change disease (MCD) is a common cause of nephrotic syndrome in children and adults. Immune dysregulation is a contributor, but the relative roles of individual components of the...
2.
Koirala A, Akilesh S, Jefferson J
Adv Kidney Dis Health
. 2024 Jul;
31(4):290-298.
PMID: 39084754
Collapsing glomerulopathy (CG) is a pattern of kidney injury characterized by segmental or global collapse of the glomerular tuft associated with overlying epithelial cell hyperplasia. Although CG may be idiopathic,...
3.
Pengshung M, Charu V, Troxell M, Akilesh S, Smith K, Jefferson J
Kidney Med
. 2024 Jul;
6(7):100841.
PMID: 38966682
Antibrush border antibody (ABBA) disease is a rare cause of kidney disease characterized by progressive renal tubular injury associated with immune complex deposition along the basement membranes of the proximal...
4.
Avasare R, Drexler Y, Caster D, Mitrofanova A, Jefferson J
Kidney360
. 2023 Aug;
4(10):1503-1511.
PMID: 37528520
Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global...
5.
Shankland S, Jefferson J, Wessely O
Kidney Int
. 2023 Jun;
104(3):455-462.
PMID: 37290603
The majority of podocyte disorders are progressive in nature leading to chronic kidney disease and often kidney failure. The scope of current therapies is typically nonspecific immunosuppressant medications, which are...
6.
Koirala A, Jefferson J
Glomerular Dis
. 2023 Feb;
1(4):237-249.
PMID: 36751385
Background: Minimal change disease (MCD) causes approximately 10% of nephrotic syndrome in adults. While glucocorticoids (GCs) effectively induce remission in MCD, the disease has a high relapse rate (50-75%), and...
7.
Mariani L, Eddy S, Alakwaa F, McCown P, Harder J, Nair V, et al.
Kidney Int
. 2022 Nov;
103(3):565-579.
PMID: 36442540
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, there are variable rates of progression...
8.
Andeen N, Abdulameer S, Charu V, Zuckerman J, Troxell M, Kambham N, et al.
Kidney Int Rep
. 2022 Mar;
7(3):568-579.
PMID: 35257069
Introduction: There are limited reports on kidney biopsy findings in patients with mantle cell lymphoma (MCL). Methods: We initiated a multi-institutional, retrospective review of kidney biopsy findings in patients with...
9.
Shi J, Lindo E, Baird G, Young B, Ryan M, Jefferson J, et al.
Clin Chim Acta
. 2021 May;
520:16-22.
PMID: 34052206
Background And Aims: Creatinine-based MDRD and CKD-EPI equations include a race correction factor, which results in higher eGFR in Black patients. We evaluated the impact on our patient population upon...
10.
Koirala A, Jefferson J
Clin J Am Soc Nephrol
. 2020 Oct;
15(11):1541-1542.
PMID: 33060161
No abstract available.